EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Redox-modulating macrophage biohybrid nanoplatform for targeted RIPK1-PANoptosome suppression in ischemic stroke

Wenhui Jiang, Chundongqiu Xia, Zhimeng Cui, Lanhao Shi, Wei Feng, Yu Chen, Jun Zhang

Redox Biology · 2026-02 · 89 · 103997

DOI: 10.1016/j.redox.2025.103997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Redox Biology, 2026-02. Verfasst von Wenhui Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Huadong Hospital, Shanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai Institute of Geriatrics and Gerontology, …. Hauptthemen laut MEDLINE: Macrophages, Ischemic Stroke. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission, Science and Technology Innovation Plan Of Shanghai Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disruption of redox homeostasis during reperfusion triggers a complex and dynamic neuroinflammatory cascade in ischemic stroke, posing a major barrier to precision therapy. Although cellular therapies have emerged as a promising strategy, their clinical translation is hindered by the lack of tools capable of simultaneously tracking cell delivery and modulating pathological redox imbalance in vivo. Here, we report an MRI-trackable engineered macrophage-derived biohybrid nanoplatform that integrates the inflammation-homing capacity of macrophages, the imaging functionality of ultrasmall superparamagnetic iron oxide nanoparticles, and the redox-regulating activity of 2,2,6,6-tetramethylpiperidine-1-oxyl-doped lipids to restore local redox homeostasis. Leveraging their innate tropism toward inflamed tissue, the engineered macrophages selectively accumulate at sites of post-ischemic neuroinflammation. Concurrently, their intrinsic reactive oxygen species-scavenging capability alleviates oxidative stress, thereby suppressing a redox-dependent network of programmed cell death PANoptosis. In vivo ischemic stroke models demonstrate that this redox-modulating biohybrid nanoplatform significantly inhibits oxidative stress-induced PANoptosis, leading to enhanced neuronal survival and improved neurological recovery. Notably, the engineered macrophages function as both redox state imagers and active modulators, enabling real-time visualization and spatiotemporal regulation of redox dynamics within the ischemic brain. Collectively, this work establishes a precision theranostic strategy to disrupt the oxidative stress-PANoptosis axis and highlights a broadly applicable platform for the treatment of oxidative stress and inflammation associated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesIschemic StrokeAnimalsOxidation-ReductionMiceOxidative StressHumansReactive Oxygen SpeciesDisease Models, AnimalMagnetic Resonance ImagingNanoparticles

Stichwörter der Autor:innen

Anti-inflammationCell trackingIschemic strokeLive cell therapyPANoptosis regulation

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Department of Radiology, Huadong Hospital, Shanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai Institute of Geriatrics and Gerontology, State Key Laboratory of Brain Function and Disorders, Fudan University…
  • Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, PR China.
  • Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, PR China. Electronic address: fengw@shu.edu.cn.
  • Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, PR China. Electronic address: chenyuedu@shu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Health Commission
  • Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
  • Science and Technology Commission of Shanghai Municipality
  • National Key Research and Development Program of China

Zitieren

APA

Jiang, W., Xia, C., Cui, Z., Shi, L., Feng, W., Chen, Y., & Zhang, J. (2026). Redox-modulating macrophage biohybrid nanoplatform for targeted RIPK1-PANoptosome suppression in ischemic stroke. Redox Biology, 89, 103997. https://doi.org/10.1016/j.redox.2025.103997

Vancouver

Jiang W, Xia C, Cui Z, Shi L, Feng W, Chen Y, et al. Redox-modulating macrophage biohybrid nanoplatform for targeted RIPK1-PANoptosome suppression in ischemic stroke. Redox Biology. 2026;89:103997. doi:10.1016/j.redox.2025.103997

BibTeX
@article{Jiang2026,
  author = {Jiang, Wenhui and Xia, Chundongqiu and Cui, Zhimeng and Shi, Lanhao and Feng, Wei and Chen, Yu and Zhang, Jun},
  title = {Redox-modulating macrophage biohybrid nanoplatform for targeted RIPK1-PANoptosome suppression in ischemic stroke},
  journal = {Redox Biology},
  year = {2026},
  volume = {89},
  pages = {103997},
  doi = {10.1016/j.redox.2025.103997}
}
Kostenlos starten →